Search Results - Devan V. Mehrotra

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods

    Pharmacogenomics polygenic risk score for drug response prediction using PRS-PGx methods by Song Zhai, Hong Zhang, Devan V. Mehrotra, Judong Shen

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    An Ad5-Vectored HIV-1 Vaccine Elicits Cell-mediated Immunity but does not Affect Disease Progression in HIV-1–infected Male Subjects: Results From a Randomized Placebo-Controlled Trial (The Step Study)

    An Ad5-Vectored HIV-1 Vaccine Elicits Cell-mediated Immunity but does not Affect Disease Progression in HIV-1–infected Male Subjects: Results From a Randomized Placebo-Controlled T... by Daniel W. Fitzgerald, Holly Janes, Michael Robertson, Robert W. Coombs, Ian Frank, Peter B. Gilbert, Mona Loufty, Devan V. Mehrotra, Ann Duerr

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    GWAS of longitudinal trajectories at biobank scale

    GWAS of longitudinal trajectories at biobank scale by Seyoon Ko, Chris German, A. E. Jensen, Judong Shen, Anran Wang, Devan V. Mehrotra, Yan V. Sun, Janet S. Sinsheimer, Hua Zhou, Jin Zhou

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Germline HLA landscape does not predict efficacy of pembrolizumab monotherapy across solid tumor types

    Germline HLA landscape does not predict efficacy of pembrolizumab monotherapy across solid tumor types by Aparna Chhibber, Lingkang Huang, Hong Zhang, Jialin Xu, Rǎzvan Cristescu, Xiao Liu, Devan V. Mehrotra, Judong Shen, Peter Shaw, Matthew D. Hellmann, Alexandra Snyder

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Impact of Herpes Simplex Virus Type 2 on HIV-1 Acquisition and Progression in an HIV Vaccine Trial (the Step Study)

    Impact of Herpes Simplex Virus Type 2 on HIV-1 Acquisition and Progression in an HIV Vaccine Trial (the Step Study) by Ruanne V. Barnabas, Judith N. Wasserheit, Yunda Huang, Holly Janes, Rhoda Ashley Morrow, Jonathan Fuchs, Karen E. Mark, Martín Casapía, Devan V. Mehrotra, Susan Buchbinder, Lawrence Corey

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    AIDS Clinical Trials Group 5197: A Placebo‐Controlled Trial of Immunization of HIV‐1–Infected Persons with a Replication‐Deficient Adenovirus Type 5 Vaccine Expressing the HIV‐1 Core Protein

    AIDS Clinical Trials Group 5197: A Placebo‐Controlled Trial of Immunization of HIV‐1–Infected Persons with a Replication‐Deficient Adenovirus Type 5 Vaccine Expressing the HIV‐1 Co... by Robert T. Schooley, John Spritzler, Hongying Wang, Michael M. Lederman, Diane V. Havlir, Daniel R. Kuritzkes, Richard B. Pollard, Cathy Battaglia, Michael Robertson, Devan V. Mehrotra, Danilo R. Casimiro, Kara S. Cox, Barbara Schock

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B<i>gag</i>Vaccines in Healthy Adults

    Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B<i>gag</i>Vaccines in Healthy Adults by Clayton Harro, Michael Robertson, Michelle Lally, Lori D. O'Neill, Srilatha Edupuganti, Paul Goepfert, Mark J. Mulligan, Frances Priddy, Sheri Dubey, Lisa Kierstead, Xiao Sun, Danilo R. Casimiro, Mark J. DiNubile, John W. Shiver, Randi Y. Leavitt, Devan V. Mehrotra

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

    Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial by Susan Buchbinder, Devan V. Mehrotra, Ann Duerr, Daniel W. Fitzgerald, Robin Mogg, David Li, Peter B. Gilbert, Javier R. Lama, Michael Marmor, Carlos del Rı́o, M. Juliana McElrath, Danilo R. Casimiro, Keith Gottesdiener, Jeffrey Chodakewitz, Lawrence Corey, Michael Robertson

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

    HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis by M. Juliana McElrath, Stephen C. De Rosa, Zoe Moodie, Sheri Dubey, Lisa Kierstead, Holly Janes, Olivier Defawe, Donald K. Carter, John Hural, Rama Akondy, Susan Buchbinder, Michael Robertson, Devan V. Mehrotra, Steven G. Self, Lawrence Corey, John W. Shiver, Danilo R. Casimiro

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Detection of HIV Vaccine-Induced Cell-Mediated Immunity in HIV-Seronegative Clinical Trial Participants Using an Optimized and Validated Enzyme-Linked Immunospot Assay

    Detection of HIV Vaccine-Induced Cell-Mediated Immunity in HIV-Seronegative Clinical Trial Participants Using an Optimized and Validated Enzyme-Linked Immunospot Assay by Sheri Dubey, J. Clair, Tong‐Ming Fu, Liming Guan, Romnie Long, Robin Mogg, Kiersten Anderson, Kelly Collins, Christine Gaunt, Violeta Fernández, Lan Zhu, Lisa Kierstead, Scott J. Thaler, Swati B. Gupta, Walter L. Straus, Devan V. Mehrotra, Timothy W. Tobery, Danilo R. Casimiro, John W. Shiver

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine

    Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine by David W. Haas, Eduardo Arathoon, Melanie Thompson, Rogiero de Jesus Pedro, Joel E. Gallant, David Éverson Uip, Judith S. Currier, Lorena Noriega, David Salomão Lewi, Patricia Uribe, Jorge Benetucci, Pedro Cahn, Dávid Paár, A. Clinton White, Ann C. Collier, C H Ramírez-Ronda, Charlotte Harvey, Mi-ok Chung, Devan V. Mehrotra, Jeffrey Chodakewitz, Bach-Yen Nguyen

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy Adults

    Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy Adults by Frances Priddy, Deborah D. Brown, James G. Kublin, Kathleen Monahan, David P. Wright, Jacob Lalezari, Steven Santiago, Michael Marmor, Michelle Lally, Richard M. Novak, Stephen J. Brown, P.P. Kulkarni, Sheri Dubey, Lisa Kierstead, Danilo R. Casimiro, Robin Mogg, Mark J. DiNubile, John W. Shiver, Randi Y. Leavitt, Michael Robertson, Devan V. Mehrotra, Erin Quirk

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

    Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials by Devan V. Mehrotra, Holly Janes, Thomas R. Fleming, Paula W. Annunziato, Kathleen M. Neuzil, Lindsay N. Carpp, David Benkeser, Elizabeth R. Brown, Marco Carone, Iksung Cho, Deborah Donnell, Michael P. Fay, Youyi Fong, Shu Han, Ian Hirsch, Ying Huang, Yunda Huang, Ollivier Hyrien, Michal Juraska, Alex Luedtke, Martha Nason, An Vandebosch, Haiyu Zhou, Myron S. Cohen, Lawrence Corey, Jonathan Hartzel, Dean Follmann, Peter B. Gilbert

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: